The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2013A Study to Evaluate Feasibility, Safety and Preliminary Efficacy of Magnetic Resonance Image Guided Focused Ultrasound for the Treatment of Parkinson’s Disease Dyskinesia
Objective/Rationale:
The effectiveness of drug therapy to alleviate Parkinson’s disease (PD) symptoms often diminishes over time, and side effects such as dyskinesia (involuntary... -
MJFF Research Grant, 2013Transcutaneous Submandibular Gland Biopsy: A Diagnostic Test for Early Parkinson’s Disease
Objective/Rationale:
We have previously found that in autopsied patients with Parkinson’s disease (PD) the hallmark finding in the brain (Lewy-type alpha synuclein staining or LTS) is... -
Target Validation, 2012Targeting the JAK/STAT Pathway in the Treatment of Parkinson's Disease
Objective/Rationale:
Parkinson’s disease (PD) involves inappropriate activation of the immune system. Cytokines activate immune cells by engaging the JAK/STAT pathway, which receives signals from... -
MJFF Research Grant, 2012The Role of Amyloid in the Progression of Cognitive Impairment in PD: A Prospective Cohort Study
Objective/Rationale:
Dementia is a frequent and devastating non-motor complication of Parkinson's disease (PD). Although loss of dopamine producing brain cells play a role in cognitive... -
Target Validation, 2012Evaluation of the Microtubule-Stabilizing Agent, Epothilone D, in Mouse Models of Parkinson's Disease
Objective/Rationale:
Microtubules are critical components within nerve cells, where they serve as the “railroad” tracks upon which cellular cargo is transported up and down the length of... -
Rapid Response Innovation Awards, 2013Neuromelanin in Circulating Phagocytes May Reveal Early Neurodegeneration in Parkinson’s Disease
Objective/Rationale:
A normal function of inflammation is to recruit phagocytic white blood cells (think PACMAN) to clear away the damaged cells. We postulate that debris laden PACMEN re...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.